Markus Ringnér

Alıntı yapanlar

	Hepsi	2020 yılından bugüne
Alıntılar	34938	19737
h-endeksi	70	46
i10-endeksi	120	88

4300

2150

1075

3225

200220032004200520062007200820092010201120122013201420152016201720182019202020212022202320242025226 394 508 512 586 519 573 582 780 785 889 937 1005 1095 1135 1284 1337 1561 2957 4239 4130 3860 3762 750

Genel erişim

Tümünü görüntüle

67 makale

3 makale

genel erişime açık olanlar

genel erişime açık olmayanlar

Finansman sağlayan kuruluşun getirdiği zorunluluğa dayalı olarak

Katkıda bulunan yazarlar

Åke BorgDepartment of Oncology, Clinical Sciences, Lund University, Swedenmed.lu.se üzerinde doğrulanmış e-posta adresine sahip
Johan StaafDepartment of Oncology, Clinical Sciences, Lund University, Swedenmed.lu.se üzerinde doğrulanmış e-posta adresine sahip
Göran JönssonProfessor, Dept. of Oncology, Clinical Sciences, Lund University, Swedenmed.lu.se üzerinde doğrulanmış e-posta adresine sahip
Paul MeltzerCenter for Cancer Research, National Cancer Institutenih.gov üzerinde doğrulanmış e-posta adresine sahip
Carsten PetersonProfessor, Computational Biology, Theoretical Physics, Lund Universitythep.lu.se üzerinde doğrulanmış e-posta adresine sahip
Johan Vallon-ChristerssonDivision of Oncology, Department of Clinical Sciences Lund, Lund University, Swedenmed.lu.se üzerinde doğrulanmış e-posta adresine sahip
Martin LaussDepartment of Oncology, Clinical Sciences, Lund University, Swedenmed.lu.se üzerinde doğrulanmış e-posta adresine sahip
Lao H SaalAssociate Professor, Lund Universitymed.lu.se üzerinde doğrulanmış e-posta adresine sahip
Javed KhanDeputy Branch Chief Genetics Branch, Senior Investigator, Center for Cancer Research, NCI, NIHmail.nih.gov üzerinde doğrulanmış e-posta adresine sahip
Mattias HöglundDepartment of Oncology, Clinical Sciences, Lund University, Swedenmed.lu.se üzerinde doğrulanmış e-posta adresine sahip
Pär-Ola BendahlAssociate Professor, Lund Universitymed.lu.se üzerinde doğrulanmış e-posta adresine sahip
David LindgrenCenter for Molecular Pathology, Lund University, Swedenmed.lu.se üzerinde doğrulanmış e-posta adresine sahip
Erik FredlundDept. Oncology-Pathology, Science for Life Laboratory, Karolinska Institutet, Stockholm, Swedenki.se üzerinde doğrulanmış e-posta adresine sahip
Peter JohanssonResearcher, QIMR Berghofer Medical Research Instituteqimrberghofer.edu.au üzerinde doğrulanmış e-posta adresine sahip
Barkardottir R BLaboratory of Cell Biology, Department of Pathology, Landspitali University Hospital, Reykjaviklandspitali.is üzerinde doğrulanmış e-posta adresine sahip
Ingrid HedenfalkDepartment of Oncology, Clinical Sciences, Lund University, Swedenmed.lu.se üzerinde doğrulanmış e-posta adresine sahip
Srinivas Sunny VeerlaScientist, Lund Universitymed.lu.se üzerinde doğrulanmış e-posta adresine sahip
Gad GetzMassachusetts General Hospital and Broad Institute of Harvard and MITbroadinstitute.org üzerinde doğrulanmış e-posta adresine sahip
Mattias AineAffiliated researcher, Division of Oncology & Pathology, Lund Universitymed.lu.se üzerinde doğrulanmış e-posta adresine sahip
Bjarni Agnar AgnarssonProfessor of Pathologylandspitali.is üzerinde doğrulanmış e-posta adresine sahip

Takip et

Markus Ringnér

Science for Life Laboratory and Lund University

scilifelab.se üzerinde doğrulanmış e-posta adresine sahip

Bioinformatics Genomics Epigenetics


Başlık Alıntılara göre sırala Yıla göre sırala Başlığa göre sırala	Alıntı yapanlar Alıntı yapanlar	Yıl
Classification and diagnostic prediction of cancers using gene expression profiling and artificial neural networks J Khan, JS Wei, M Ringnér, LH Saal, M Ladanyi, F Westermann, ... Nature Medicine 7 (6), 673-679, 2001	3613	2001
The repertoire of mutational signatures in human cancer LB Alexandrov, J Kim, NJ Haradhvala, MN Huang, AW Tian Ng, Y Wu, ... Nature 578 (7793), 94-101, 2020	2963	2020
What is principal component analysis? M Ringnér Nature Biotechnology 26 (3), 303-304, 2008	2950	2008
Landscape of somatic mutations in 560 breast cancer whole-genome sequences S Nik-Zainal, H Davies, J Staaf, M Ramakrishna, D Glodzik, X Zou, ... Nature 534 (7605), 47-54, 2016	2383	2016
Pan-cancer analysis of whole genomes Nature 578 (7793), 82-93, 2020	2375	2020
Exosomes reflect the hypoxic status of glioma cells and mediate hypoxia-dependent activation of vascular cells during tumor development P Kucharzewska, HC Christianson, JE Welch, KJ Svensson, E Fredlund, ... Proceedings of the National Academy of Sciences 110 (18), 7312-7317, 2013	1029	2013
The evolutionary history of 2,658 cancers M Gerstung, C Jolly, I Leshchiner, SC Dentro, S Gonzalez, D Rosebrock, ... Nature 578 (7793), 122-128, 2020	1025	2020
A molecular taxonomy for urothelial carcinoma G Sjödahl, M Lauss, K Lövgren, G Chebil, S Gudjonsson, S Veerla, ... Clinical Cancer Research 18 (12), 3377-3386, 2012	980	2012
Estrogen receptor status in breast cancer is associated with remarkably distinct gene expression patterns S Gruvberger, M Ringnér, Y Chen, S Panavally, LH Saal, Å Borg, M Fernö, ... Cancer Research 61 (16), 5979-5984, 2001	916	2001
Patterns of somatic structural variation in human cancer genomes Y Li, ND Roberts, JA Wala, O Shapira, SE Schumacher, K Kumar, ... Nature 578 (7793), 112-121, 2020	831	2020
The CD44+/CD24- phenotype is enriched in basal-like breast tumors G Honeth, PO Bendahl, M Ringnér, LH Saal, SK Gruvberger-Saal, ... Breast Cancer Research 10 (3), R53, 2008	717	2008
Spatially and functionally distinct subclasses of breast cancer-associated fibroblasts revealed by single cell RNA sequencing M Bartoschek, N Oskolkov, M Bocci, J Lövrot, C Larsson, M Sommarin, ... Nature Communications 9, 5150, 2018	698	2018
Impact of DNA amplification on gene expression patterns in breast cancer E Hyman, P Kauraniemi, S Hautaniemi, M Wolf, S Mousses, E Rozenblum, ... Cancer Research 62 (21), 6240-6245, 2002	669	2002
Comprehensive analysis of chromothripsis in 2,658 human cancers using whole-genome sequencing I Cortés-Ciriano, JJK Lee, R Xi, D Jain, YL Jung, L Yang, D Gordenin, ... Nature Genetics 52 (3), 331-341, 2020	650	2020
Poor prognosis in carcinoma is associated with a gene expression signature of aberrant PTEN tumor suppressor pathway activity LH Saal, P Johansson, K Holm, SK Gruvberger-Saal, QB She, M Maurer, ... Proceedings of the National Academy of Sciences 104 (18), 7564-7569, 2007	647	2007
Analyses of non-coding somatic drivers in 2,658 cancer whole genomes E Rheinbay, MM Nielsen, F Abascal, JA Wala, O Shapira, G Tiao, ... Nature 578 (7793), 102-111, 2020	585	2020
GOBO: gene expression-based outcome for breast cancer online M Ringnér, E Fredlund, J Häkkinen, Å Borg, J Staaf PLoS ONE 6 (3), e17911, 2011	434	2011
Mutational and putative neoantigen load predict clinical benefit of adoptive T cell therapy in melanoma M Lauss, M Donia, K Harbst, R Andersen, S Mitra, F Rosengren, M Salim, ... Nature Communications 8, 1738, 2017	419	2017
Pan-cancer analysis of whole genomes identifies driver rearrangements promoted by LINE-1 retrotransposition B Rodriguez-Martin, EG Alvarez, A Baez-Ortega, J Zamora, F Supek, ... Nature Genetics 52 (3), 306-319, 2020	393	2020
The landscape of viral associations in human cancers M Zapatka, I Borozan, DS Brewer, M Iskar, A Grundhoff, M Alawi, N Desai, ... Nature Genetics 52 (3), 320-330, 2020	382	2020

Sistem, işlemi şu anda gerçekleştiremiyor. Daha sonra yeniden deneyin.

Makaleler 1–20

Yıllık alıntı sayısı

Mükerrer alıntılar

Birleştirilmiş alıntılar

Katkıda bulunan yazar ekleKatkıda bulunan yazarlar

Takip et

Alıntı yapanlar

Katkıda bulunan yazarlar